LOUISVILLE, Colo.,
March 20, 2026 /CNW/ - (TSX: CWEB)
(OTCQB: CWBHF) Charlotte's Web Holdings, Inc. (the "Company" or "Charlotte's Web"), a botanical wellness innovation company and the market leader in
cannabidiol ("CBD") hemp extract wellness products, extends its
sincere appreciation to the Centers for Medicare & Medicaid Services
(CMS) and the Administration for their leadership in advancing structured
access to eligible full‑spectrum hemp products through current CMS
Innovation Center models, as reflected in CMS's new Substance Access
Beneficiary Engagement Incentive (BEI)
guidance pages. Under the BEI, CMS has defined eligible hemp products to include products
containing up to 3 mg per serving of tetrahydrocannabinols, a threshold that
accommodates non-intoxicating full-spectrum hemp-derived CBD products. This
forward‑looking framework supports patient‑provider discussions around
eligible hemp products, reinforcing science‑driven policymaking that
prioritizes consumer safety and product quality.
"We are grateful for CMS's thoughtful approach in expanding access and
creating space for responsible, evidence based hemp wellness conversations
in clinical settings," saidBill Morachnick, CEO of Charlotte's Web."This
program aligns with our mission to advance safe, high quality, science
backed hemp options for consumers, and we remain committed to supporting
sensible legislation that protects patients and strengthens the integrity of
our industry."
Charlotte's Web will continue to champion policy solutions that uphold
safety, transparency, and the availability of trusted full‑spectrum hemp
products.
About Charlotte's Web Holdings, Inc.
Charlotte's Web Holdings,
Inc., a Certified B Corporation headquartered in Louisville, Colorado, is a
botanical wellness innovation company and market leader in hemp extract
wellness. The Company's product categories include CBD oil tinctures (liquid
products), CBD gummies (sleep, calming, exercise recovery), CBN gummies, CBG
gummies, hemp-derived THC microdose gummies, functional mushroom gummies,
CBD capsules, CBD topical creams and lotions, as well as CBD pet products
for dogs. Through its substantially vertically integrated business model,
Charlotte's Web maintains stringent control over product quality and
consistency with analytic testing for quality assurance. Charlotte's Web
products are distributed to retailers and healthcare practitioners
throughout the U.S.A. and are available online through the Company's website
at
www.charlottesweb.com.
Forward-Looking Information
Certain information provided herein constitutes forward-looking
statements or information (collectively, "forward-looking statements")
within the meaning of applicable securities laws. Forward-looking
statements are typically identified by words such as "may," "will,"
"should," "could," "anticipate," "expect," "project," "estimate,"
"forecast," "plan," "intend," "target," "believe" and similar words
suggesting future outcomes or statements regarding an outlook.
Forward-looking statements are not guarantees of future performance and
readers are cautioned against placing undue reliance on forward-looking
statements. This press release includes forward-looking statements
pertaining to, among other things, the Company's beliefs regarding product
eligibility under CMS programs, the potential scope and impact of federal
healthcare frameworks for hemp-derived products, the Company's competitive
positioning, and its ability to participate in federal healthcare
programs. By their nature, these statements involve a variety of
assumptions, known and unknown risks and uncertainties, and other factors
which may cause actual results, levels of activity, and achievements to
differ materially from those expressed or implied by such statements. The
material factors and assumptions used to develop the forward-looking
statements herein include material risk factors that could cause actual
results to differ materially from the forward-looking statements
including, among others, general economic and market risks, regulatory and
policy risks, the risk that CMS may modify or discontinue the referenced
programs, the risk that the Company's products may not ultimately meet all
eligibility requirements. These and other risks and uncertainties
discussed under the heading "Risk Factors" in the Company's Annual Report
on Form 10-K for the year ending December 31, 2024, and other risk factors
contained in other filings with the Securities and Exchange Commission
available on www.sec.gov
and filings with Canadian securities regulatory authorities available on www.sedarplus.ca. The impact of any one risk, uncertainty, or factor on a particular
forward-looking statement is not determinable with certainty as these are
interdependent, and the Company's future course of action depends on
management's assessment of all information available at the relevant time.
Any forward-looking statement in this press release is based only on
information currently available to the Company and speaks only as of the
date on which it is made. Except as required by applicable law, the
Company assumes no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events, or
otherwise. All forward-looking statements, whether written or oral,
attributable to the Company or persons acting on the Company's behalf, are
expressly qualified in their entirety by these cautionary statements.
View original content to download multimedia:https://www.prnewswire.com/news-releases/charlottes-web-welcomes-new-cms-guidance-advancing-access-to-eligible-fullspectrum-hemp-products-302720320.html
SOURCE Charlotte's Web Holdings, Inc.